Behçet's disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Behçet's disease}} {{CMG}}; {{CZ}} ==Overview== The underlying pathophysiological mechanism of Behçet's disease is an overactive immune system that produces...")
 
Line 10: Line 10:


Behçet's disease usually first affects patients when they are in their 20s and 30s. It then becomes a fluctuating lifelong disorder with a series of [[remission]]s and exacerbations which can last from days to months. Complete remission is rare.
Behçet's disease usually first affects patients when they are in their 20s and 30s. It then becomes a fluctuating lifelong disorder with a series of [[remission]]s and exacerbations which can last from days to months. Complete remission is rare.
==Gross Pathology==
[[File:Behcet's syndrome 11.jpeg|Behcet's disease|50px]]


==References==
==References==

Revision as of 14:20, 10 March 2017

Behçet's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Behçet's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Behçet's disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Behçet's disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Behçet's disease pathophysiology

CDC on Behçet's disease pathophysiology

Behçet's disease pathophysiology in the news

Blogs on Behçet's disease pathophysiology</smal

Directions to Hospitals Treating Behçet's disease

Risk calculators and risk factors for Behçet's disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Cafer Zorkun, M.D., Ph.D. [2]

Overview

The underlying pathophysiological mechanism of Behçet's disease is an overactive immune system that produces recurrent outbreaks of inflammation in small blood vessels. Common symptoms include mouth ulcers, genital ulcers, eye inflammation, and arthritis in older patients.

Pathophysiology

The symptoms of Behçet's disease are believed to be caused by an over-active immune system which, without any apparent infections, produces recurrent outbreaks of inflammation in small blood vessels. Common symptoms include mouth ulcers, genital ulcers, eye inflammation, and arthritis in older patients. The symptoms are mostly painful but not life threatening. Some patients however experience significant impairment due to pain, impaired vision and reduced mobility, and may be disabled and unable to work due to this condition. In some severe cases, uncontrolled inflammation may lead to blindness, intestinal complications, stroke, and even meningitis, which can be fatal.

Behçet's disease usually first affects patients when they are in their 20s and 30s. It then becomes a fluctuating lifelong disorder with a series of remissions and exacerbations which can last from days to months. Complete remission is rare.

Gross Pathology

Behcet's disease

References

Template:WH Template:WS